Cell-surface antigens of melanoma recognized by human monoclonal antibodies.
AUTOR(ES)
Yamaguchi, H
RESUMO
Human monoclonal antibodies (mAbs) were derived from lymph node lymphocytes and peripheral blood lymphocytes (PBL) from patients with melanoma. Four methods for generating human mAbs were compared: fusion with human [LICR-LON-HMy-2 (LICR-2)] or mouse (NS-1) cells; transformation by Epstein-Barr virus (EBV); and EBV transformation followed by NS-1 fusion. NS-1 fusion with lymph node lymphocytes resulted in a higher number of growing hybrids than LICR-2 fusion. Virtually no hybrids were obtained from NS-1 or LICR-2 fusions with PBL. EBV transformed lymphocytes from lymph node and peripheral blood with equal efficiency, and the yield of proliferating cultures for antibody screening was more than 10- to 30-fold greater than that obtained by fusion techniques. However, once antibody-producing cultures had been identified, stability and clonability of EBV-transformed cells were poorer than that of NS-1 hybrid cells. To combine the strengths of both methods, cultures of EBV-transformed cells were fused with NS-1; and hybrid clones were isolated that showed vigorous growth, clonability, and stable antibody secretion. Detailed specificity analysis of the mAbs produced by six of these clones indicated detection of a class 1 (unique) melanoma antigen, a class 3 melanoma antigen, and four ganglioside antigens (GD3, GM3, and two other, as yet uncharacterized, heterophile antigens).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=304662Documentos Relacionados
- Human trophoblast cell-surface antigens defined by monoclonal antibodies.
- Human peripheral blood monocytes display surface antigens recognized by monoclonal antinuclear antibodies.
- Detection of Dengue Cell-Surface Antigens by Peroxidase-Labeled Antibodies and Immune Cytolysis
- Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
- Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.